CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.34%)
At close: Aug 21, 2026 · 4:00 PM EDT

CervoMed (CRVO) Change in Acquisitions & Divestments (2015 - 2026)

CervoMed (CRVO) posted Change in Acquisitions & Divestments of $8.7 million for Q1 2026, down 13.0% sequentially from $10.0 million in Q4 2025, and down 30.4% YoY from $12.5 million in Q1 2025.

CervoMed (CRVO) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends

CervoMed has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $8.7 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 30.4% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.7 million (up 24.3% YoY) and the FY2025 annual result came in at $43.5 million, up 123.77% from the prior year.
  • Change in Acquisitions & Divestments fell to $8.7 million in Q1 2026 per CRVO's latest filing, from $10.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $12.9 million in Q4 2024 and troughed at -$12.5 million in Q3 2023.
  • A 5-year average of $7.5 million and a median of $9.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments tumbled 228.21% in 2023, then surged 152.0% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $7.0 million in 2022, then slumped by 278.57% to -$12.5 million in 2023, then soared by 203.52% to $12.9 million in 2024, then decreased by 22.72% to $10.0 million in 2025, then decreased by 13.0% to $8.7 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $8.7 million, $10.0 million, and $11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CervoMed 26.64 Mn 26.64 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 5.00 Mn
Jun 30, 2026 5.00 Mn
Mar 31, 2026 8.70 Mn
Mar 31, 2026 8.70 Mn
Dec 31, 2025 10.00 Mn
Dec 31, 2025 10.00 Mn
Sep 30, 2025 11.50 Mn
Sep 30, 2025 11.50 Mn
Jun 30, 2025 9.50 Mn
Jun 30, 2025 9.50 Mn
Mar 31, 2025 12.50 Mn
Mar 31, 2025 12.50 Mn
Dec 31, 2024 12.94 Mn
Dec 31, 2024 12.94 Mn
Sep 30, 2024 6.50 Mn
Sep 30, 2024 6.50 Mn
Sep 30, 2023 -12.50 Mn
Sep 30, 2023 -12.50 Mn
Jun 30, 2023 3.00 Mn
Jun 30, 2023 3.00 Mn